Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6100+0.0810 (+15.31%)
At close: 04:00PM EDT
0.5780 -0.03 (-5.25%)
After hours: 07:40PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.060.01-0.080.1
Low estimate-0.060.01-0.080.1
High estimate-0.060.01-0.080.1
Year ago EPS-0.56-0.51-2.33-0.08
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate2.98M4.1M13.68M21.9M
Low estimate2.98M4.1M13.68M21.9M
High estimate2.98M4.1M13.68M21.9M
Year ago sales1.13M1.56M5.18M13.68M
Sales growth (year/est)163.50%162.30%164.00%60.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.73-0.62-0.5-0.21
Actual EPS-0.56-0.51-0.59-0.17
Difference0.170.11-0.090.04
Surprise %23.30%17.70%-18.00%19.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.060.01-0.080.1
7 days ago-0.060.01-0.080.1
30 days ago-0.060.01-0.080.1
60 days ago-0.14-0.02-0.230.03
90 days ago-0.14-0.02-0.23-0.08
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.89.30%N/AN/AN/A
Next qtr.102.00%N/AN/AN/A
Current year96.60%N/AN/AN/A
Next year225.00%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A